Frequency of the c.130dupG CHRNE mutation in Brazilian patients with CMS


The most common causes of congenital myasthenic syndromes (CMS) are CHRNE mutations, and some pathogenic allelic variants in this gene are especially frequent in certain ethnic groups. In the southern region of Brazil, a study found the c.130dupG CHRNE mutation in up to 33% of families with CMS. Here, the authors aimed to verify the frequency of this mutation among individuals with CMS in a larger cohort of CMS patients from different areas of Brazil and to characterize clinical features of these patients. Eighty-four patients with CMS, from 72 families, were clinically evaluated and submitted to direct sequencing of the exon 2 of CHRNE. The c.130dupG mutation was found in 32 patients (23 families), with 26 patients (19 families, 26.3%) in homozygosis, confirming its high prevalence in different regions of Brazil. Among the homozygous patients, the following characteristics were frequent: onset of symptoms before 2 years of age (92.3%), little functional restriction (92.3%), fluctuating symptoms (100%), ocular muscle impairment (96.1%), ptosis (100%), limb weakness (88.4%), response to pyridostigmine (100%), facial involvement (77%), and bulbar symptoms (70.8%). The authors conclude that the CHRNE mutation c.130dupG leads to fairly benign natural course of the disease with relative homogeneity.

Estephan EP, Sobreira CFDR, Dos Santos ACJ, et al. A common CHRNE mutation in Brazilian patients with congenital myasthenic syndrome. J Neurol. 2018 Jan 30. doi: 10.1007/s00415-018-8736-8. [Epub ahead of print]